It sounds to me they are just being “scientists” and conducting more tests on it... why I am not exactly sure. They should give clear reasons why considering our competitors haven’t.
It still seems like it would be the surrogate testing via direct inoculation can someone confirm why they would do this test in more detail,?
- Forums
- ASX - By Stock
- Holista CollTech joins forces with GICC to develop works first nasal sanitiser
It sounds to me they are just being “scientists” and conducting...
- There are more pages in this discussion • 303 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.788M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
HCT (ASX) Chart |
Day chart unavailable